These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 37534206)

  • 1. Role of extracellular vesicles in nonalcoholic fatty liver disease.
    Jiang W; Xu Y; Chen JC; Lee YH; Hu Y; Liu CH; Chen E; Tang H; Zhang H; Wu D
    Front Endocrinol (Lausanne); 2023; 14():1196831. PubMed ID: 37534206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy.
    Hernández A; Arab JP; Reyes D; Lapitz A; Moshage H; Bañales JM; Arrese M
    Cells; 2020 Mar; 9(4):. PubMed ID: 32231001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial and eukaryotic extracellular vesicles and nonalcoholic fatty liver disease: new players in the gut-liver axis?
    Villard A; Boursier J; Andriantsitohaina R
    Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G485-G495. PubMed ID: 33471632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1.
    Jiang F; Chen Q; Wang W; Ling Y; Yan Y; Xia P
    J Hepatol; 2020 Jan; 72(1):156-166. PubMed ID: 31568800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of detection of extracellular vesicles in the diagnosis of nonalcoholic fatty liver disease].
    Jiang WY; Xun YH
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):92-96. PubMed ID: 32023709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNA‑135a‑3p in serum extracellular vesicles as a potential biological marker of non‑alcoholic fatty liver disease.
    Jiang H; Qian Y; Shen Z; Liu Y; He Y; Gao R; Shen M; Chen S; Fu Q; Yang T
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33955511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: Novel therapeutic targets.
    Yang L; Hao Y; Boeckmans J; Rodrigues RM; He Y
    Pharmacol Ther; 2023 Mar; 243():108353. PubMed ID: 36738973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human milk-derived extracellular vesicles alleviate high fat diet-induced non-alcoholic fatty liver disease in mice.
    Jiang X; Wu Y; Zhong H; Zhang X; Sun X; Liu L; Cui X; Chi X; Ji C
    Mol Biol Rep; 2023 Mar; 50(3):2257-2268. PubMed ID: 36575319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promise of small particles: extracellular vesicles as biomarkers in liver pathology.
    Srinivas AN; Suresh D; Kaur S; Kumar DP
    J Physiol; 2023 Nov; 601(22):4953-4971. PubMed ID: 35708653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Vesicles as Biomarkers in Liver Disease.
    Muñoz-Hernández R; Rojas Á; Gato S; Gallego J; Gil-Gómez A; Castro MJ; Ampuero J; Romero-Gómez M
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver Disease.
    Ban LA; Shackel NA; McLennan SV
    Int J Mol Sci; 2016 Mar; 17(3):376. PubMed ID: 26985892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets.
    Szabo G; Momen-Heravi F
    Nat Rev Gastroenterol Hepatol; 2017 Aug; 14(8):455-466. PubMed ID: 28634412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights Into Extracellular Vesicles as Biomarker of NAFLD Pathogenesis.
    Garcia-Martinez I; Alen R; Rada P; Valverde AM
    Front Med (Lausanne); 2020; 7():395. PubMed ID: 32850903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease.
    Povero D; Eguchi A; Li H; Johnson CD; Papouchado BG; Wree A; Messer K; Feldstein AE
    PLoS One; 2014; 9(12):e113651. PubMed ID: 25470250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.
    Sil S; Dagur RS; Liao K; Peeples ES; Hu G; Periyasamy P; Buch S
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):422-442. PubMed ID: 31456107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current understanding of the role of Adipose-derived Extracellular Vesicles in Metabolic Homeostasis and Diseases: Communication from the distance between cells/tissues.
    Li CJ; Fang QH; Liu ML; Lin JN
    Theranostics; 2020; 10(16):7422-7435. PubMed ID: 32642003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis.
    Zhu Q; Li H; Ao Z; Xu H; Luo J; Kaurich C; Yang R; Zhu PW; Chen SD; Wang XD; Tang LJ; Li G; Huang OY; Zheng MH; Li HP; Liu F
    J Nanobiotechnology; 2022 Jul; 20(1):349. PubMed ID: 35897102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the immune system in the pathogenesis of NAFLD and potential therapeutic impacts of mesenchymal stem cell-derived extracellular vesicles.
    Moayedfard Z; Sani F; Alizadeh A; Bagheri Lankarani K; Zarei M; Azarpira N
    Stem Cell Res Ther; 2022 Jun; 13(1):242. PubMed ID: 35672797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron-loaded extracellular vesicles: angel or demon?
    Chen H; Tang Y
    Free Radic Res; 2023 Jan; 57(1):61-68. PubMed ID: 36927327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles in fatty liver disease and steatohepatitis: Role as biomarkers and therapeutic targets.
    Eguchi A; Iwasa M; Nakagawa H
    Liver Int; 2023 Feb; 43(2):292-298. PubMed ID: 36462157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.